Asthma
Practice Essentials Asthma is a common chronic disease worldwide and affects approximately 26 million persons in the United States. It is...
Coronavirus Disease 2019 Treatment and Guidelines
Treatment & Management Approach Considerations Utilization of programs established by the FDA to allow clinicians to gain access to...
Coronavirus Disease 2019 (COVID-19) Part 1
Overview Practice Essentials Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus called severe acute...
Cavernous Sinus Thrombosis
Background Cavernous sinus thrombosis (CST) was initially described by Bright in 1831 as a complication of epidural and subdural...
The Approach to the Poisoned Patient
Overview Most toxicologic exposures involve ingestions or localized chemical/biologic exposures involving single individuals with limited...
Hemorrhagic Stroke
Practice Essentials In hemorrhagic stroke, bleeding occurs directly into the brain parenchyma. The usual mechanism is thought to be...
Hemolytic-Uremic Syndrome
Practice Essentials Hemolytic-uremic syndrome (HUS) is a clinical syndrome characterized by progressive renal failure that is associated...
Three Stages to COVID-19 Brain Damage, New Review
This is a review of diverse studies froom January to June on Covid 19 and neurological damage.
Septic Shock
Practice Essentials Sepsis is defined as life-threatening organ dysfunction due to dysregulated host response to infection, and organ...
The Great Invader: How COVID-19 AttacksEvery Organ
We have underestimated and misunderstood COVID-19 since it first appeared. And as we learn more, it's clear that COVID-19 can be more...
